Vivasvan Vykunta
@VivaVykunta
Followers
90
Following
57
Statuses
30
MD-PhD Student @UCSF_MSTP with @MaxKrummel | Previously @MarsonLab @GladstoneInst and Zikherman Lab @UCSF | Immuno-engineering and biking
California
Joined September 2021
Thrilled to share our paper now out @NatureBiotech! High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
3
9
53
RT @j_eyquem: 🚨Excited to share our latest work, now out in @NatureBiotech ! We introduce SEED-Selection, a powerful method that enables hi…
0
36
0
RT @NatureBiotech: SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci htt…
0
25
0
Excited to share this new piece! From taking art classes together back in grade school and visiting colleges together in high school to now being co-first authors, I'm looking forward to continue working and learning with @rishabrama in our future training and careers!
Excited to share our new review on altered cancer metabolism and implications for next-generation CAR T-cell therapies-- written with @VivaVykunta @GustVandeca @LGKRichardson @WTCNeuroscience
@BryanDChoi @MGHNeurosurg Full Paper:
0
1
7
RT @SciImmunology: New research in mice indicates that #MastCells secrete an essential metabolite in Peyer’s patches needed for the product…
0
9
0
RT @LabWaggoner: Intestinal IgA production depends on GPR35-expressing cDC2 positioning guided by mast cells within Peyer’s patches @MarcoD…
0
17
0
First paper from my time in @UCSF_MSTP is out today @SciImmunology! Had a blast learning from and working with @MarcoDegiov89 and the whole Cyster Lab @UCSF -- looking forward to seeing how the De Giovanni Lab continues this work!
Excited to share our latest results published in @SciImmunology unravelling how mast cells control dendritic cell positioning to sustain intestinal IgA production #Cysterlab @ArmeniseHarvard @SanRaffaeleMI @UCSF
1
1
16
RT @j_eyquem: 🚨 New study for the lab! We developed SEED selection, a method to purify KnockIns at multiple loci in a single step. Better,…
0
20
0
RT @bioRxiv_synbio: Ultra-high efficiency T cell reprogramming at multiple loci with SEED-Selection #biorxiv_syn…
0
3
0
Sister’s doing a lot of big science on the other side of campus! 👏🏽
Akshara (proudly too cool for Twitter/X/whatever) presenting her honors thesis research from @LabRaleigh at @UCBerkeley. Look for her graduate school application in 2024, folks! @UCSFGradDiv @UCSFCancer @UCSF @NeurosurgUCSF
0
0
7
RT @NatImmunol: Zikherman and colleagues describe a new mechanism by which B cells recognize virus-like antigen display as a stand-alone da…
0
20
0
Great to see this published and thankful to have played a small part in this story during my time with @MarsonLab! Enjoyed working with my previous roommate, Dan, to develop ideas together -- Excited to see how this new tech impacts the genome engineering space!!
I’m excited to share our report - out now in @natBME - of a new approach to CRISPR delivery that is poised to transform the way engineered T cell therapies are manufactured. Visit for “how to” details. It’s threadin’ time! (1/11)
0
0
7
RT @biorxiv_immuno: Molecular basis for potent B cell responses to antigen displayed on particles of viral size #b…
0
2
0
RT @Masopust_Vezys: Authored by Andrew G. Soerens et al, we show that #Tcells are capable of proliferating in response to iterative stimula…
0
409
0
RT @NatureBiotech: Combinations of single-stranded DNA repair templates and small molecules markedly enhance genome editing
0
26
0
RT @DrAlexisTalbot: I am very grateful for this fantastic paper and this incredible opportunity to collaborate with so many amazing authors…
0
5
0
RT @UrnovFyodor: Big statement coming up: This technology will, in the next decade, supersede both lentivirus and editing+AAV. This super…
0
14
0
And a huge thank you to @brshy—a wonderful mentor and my co-first author—and @MarsonLab for providing me the space to explore cellular engineering. Now, I can’t wait to build on this work further during my next few years @UCSFMedicine and @UCSF_MSTP.
0
0
3